PYC Therapeutics Limited (PYC.AX)
AUD 1.41
(-6.0%)
AUD 1.41
(-6.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 1.11 Million AUD | 252.72% |
| 2023 | 315.48 Thousand AUD | -66.57% |
| 2022 | 943.76 Thousand AUD | 29.22% |
| 2021 | 730.35 Thousand AUD | -8.49% |
| 2020 | 798.14 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | -100.0% |
| 2010 | 1.23 Million AUD | 20.42% |
| 2009 | 1.02 Million AUD | 14402.51% |
| 2008 | 7087.00 AUD | -26.78% |
| 2007 | 9679.00 AUD | -23.81% |
| 2006 | 12.7 Thousand AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 544.2 Thousand AUD | 0.0% |
| 2024 Q4 | 1.11 Million AUD | 0.0% |
| 2024 FY | 1.11 Million AUD | 252.72% |
| 2023 FY | 315.48 Thousand AUD | -66.57% |
| 2023 Q4 | 315.48 Thousand AUD | 0.0% |
| 2023 Q2 | 669.09 Thousand AUD | 0.0% |
| 2022 Q2 | 673.6 Thousand AUD | 0.0% |
| 2022 Q4 | 943.76 Thousand AUD | 0.0% |
| 2022 FY | 943.76 Thousand AUD | 29.22% |
| 2021 Q4 | 730.35 Thousand AUD | 0.0% |
| 2021 Q2 | 763.03 Thousand AUD | 0.0% |
| 2021 FY | 730.35 Thousand AUD | -8.49% |
| 2020 Q2 | 871.44 Thousand AUD | 0.0% |
| 2020 FY | 798.14 Thousand AUD | 0.0% |
| 2020 Q4 | 798.14 Thousand AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | -100.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 Q4 | 1.23 Million AUD | 0.0% |
| 2010 FY | 1.23 Million AUD | 20.42% |
| 2009 FY | 1.02 Million AUD | 14402.51% |
| 2009 Q4 | 1.02 Million AUD | 0.0% |
| 2008 Q4 | 7087.00 AUD | 0.0% |
| 2008 FY | 7087.00 AUD | -26.78% |
| 2007 Q4 | 9679.00 AUD | 0.0% |
| 2007 FY | 9679.00 AUD | -23.81% |
| 2006 FY | 12.7 Thousand AUD | 0.0% |
| 2006 Q4 | 12.7 Thousand AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -798.456% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 80.317% |
| Biome Australia Limited | 1.3 Million AUD | 14.776% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -61.346% |
| Imugene Limited | 1.54 Million AUD | 28.064% |
| Noxopharm Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -236.714% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -251.71% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.994% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -26.485% |
| Starpharma Holdings Limited | 3.52 Million AUD | 68.458% |
| Nanollose Limited | 42.53 Thousand AUD | -2516.487% |
| Memphasys Limited | 4.41 Million AUD | 74.785% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 28.746% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -163.715% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 93.621% |
| Dimerix Limited | 149.68 Thousand AUD | -643.432% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | 9.402% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -599.671% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | 25.165% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -15507.181% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 55.391% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -4616.819% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -364.961% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -37.18% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -535.333% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -248.762% |
| Immuron Limited | 173.49 Thousand AUD | -541.39% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |